1986
DOI: 10.1590/s0004-282x1986000300002
|View full text |Cite
|
Sign up to set email alerts
|

Barbiturate-refractory epilepsy: safe schedule for therapeutic substitution

Abstract: Barbiturates are considered first line antiepileptic drugs in third world countries due to traditional and economic reasons. This prospective uncontrolled study of 52 patients aged 15 to 64 years (mean 24) demonstrates that patients who become refractory to barbiturates are mainly those with partial seizures with or without generalization or with a focal EEG abnormality (71%). Seizures tend to become refractory approximately 6 years after barbiturates were started. Progressive barbiturate withdrawal over a per… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1993
1993
1994
1994

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…To perform an initial evaluation of VGB under this concept, we selected a homogenous group of ''socially integrated and active outpatients" receiving a minimal number of other AEDs rather than the more typical patients with chronic epilepsy and polytherapy recruited into previous studies (Matilainen et al, 1988;Sander et al, 1990;Reynolds et al, 1991). In addition to the major AEDs, such chronic patients were often receiving maximal doses of BZDs and/or barbiturates, known to induce tolerance (Gorz et al, 1986;Bittencourt et al, 1993) and cognitive impairment (Thompson, 1981 ;Bigarella et al, 1991). We believed that the patient population of our study was one in which any benefit from such rational polytherapy could be measured.…”
mentioning
confidence: 99%
“…To perform an initial evaluation of VGB under this concept, we selected a homogenous group of ''socially integrated and active outpatients" receiving a minimal number of other AEDs rather than the more typical patients with chronic epilepsy and polytherapy recruited into previous studies (Matilainen et al, 1988;Sander et al, 1990;Reynolds et al, 1991). In addition to the major AEDs, such chronic patients were often receiving maximal doses of BZDs and/or barbiturates, known to induce tolerance (Gorz et al, 1986;Bittencourt et al, 1993) and cognitive impairment (Thompson, 1981 ;Bigarella et al, 1991). We believed that the patient population of our study was one in which any benefit from such rational polytherapy could be measured.…”
mentioning
confidence: 99%